Taiwan FDA registration 8d0493b6c05b4fefef42750e433e47d3

"Safety Assessment" Pylori Antibody Rapid Test Reagent (Unsterilized)

TW: "安評" 幽門桿菌抗體快速檢驗試劑 (未滅菌)
Taiwan flagTaiwan·Risk Class 1·MP BIOMEDICALS ASIA PACIFIC PTE. LTD.·Registered Dec 18, 2012 – Dec 18, 2017Cancelled
Registration details
Analysis ID
8d0493b6c05b4fefef42750e433e47d3
Customs Code
DHA04401249905
Company information
Manufacturer Country
Singapore
Authorized Representative
JOLEX INTERNATIONAL CO., LTD.
Product details
Intended Use
Limited to the first level identification range of the Measures for the Administration of Medical Devices "Helicobacter Serological Reagent (C.0003)".
Product Type (Level 1)
C Immunology and microbiology
Product Type (Level 2)
C.0003 螺旋桿菌屬血清試劑
Import Information
import
Dates and status
Registration Date
Dec 18, 2012
Expiry Date
Dec 18, 2017
Cancellation Date
Jan 17, 2019
Cancellation information
Status
Logged out
Reason
自請註銷
About this record

Access comprehensive regulatory information for "Safety Assessment" Pylori Antibody Rapid Test Reagent (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 8d0493b6c05b4fefef42750e433e47d3 and manufactured by MP BIOMEDICALS ASIA PACIFIC PTE. LTD.. The authorized representative in Taiwan is JOLEX INTERNATIONAL CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices